# Chirositol (D-Chiro-Inositol) **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chirositol **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-28 **Evidence Score:** 2 / 10 **Category:** Other **Also Known As:** D-Chiro-Inositol, DCI, Chirositol, (1R,2R,3S,5R,6S)-6-(hydroxymethyl)cyclohexane-1,2,3,4,5-pentol, D-chiro-Inositol, Pinitol derivative ## Overview D-chiro-inositol is a stereoisomer of inositol that functions as a secondary messenger in insulin signaling pathways. It participates in [glucose metabolism](/ingredients/condition/weight-management) regulation and ovarian steroidogenesis through its conversion from myo-inositol via epimerase enzymes. ## Health Benefits • Limited clinical evidence available - research dossier lacks human trial data • Plays a key role in insulin signaling pathways based on biochemical mechanisms • Involved in ovarian function regulation through cell signaling pathways • Supports metabolic regulation via insulin-dependent conversion from myo-inositol • Tissue-specific conversion rates suggest targeted metabolic effects ## Mechanism of Action D-chiro-inositol acts as a component of inositol phosphoglycans (IPGs), which serve as secondary messengers in insulin signal transduction. Upon insulin binding to its receptor, D-chiro-inositol-containing IPGs are released and activate key enzymes including pyruvate dehydrogenase and acetyl-CoA carboxylase. In ovarian tissue, D-chiro-inositol modulates steroidogenic enzyme activity and influences androgen synthesis pathways. ## Clinical Summary Current research on D-chiro-inositol is limited with minimal human clinical trial data available. Most evidence comes from biochemical and mechanistic studies demonstrating its role in cellular signaling pathways. Small preliminary studies have examined its effects on metabolic parameters, but larger randomized controlled trials are needed to establish clinical efficacy. The existing research dossier lacks sufficient human data to make definitive claims about therapeutic benefits. ## Nutritional Profile D-Chiro-Inositol (DCI) is a naturally occurring stereoisomer of inositol, a carbocyclic polyol (cyclohexanehexol) with molecular formula C6H12O6 and molecular weight 180.16 g/mol. It is not a macronutrient but a bioactive compound classified as an insulin sensitizer and secondary messenger precursor. Typical supplemental doses range from 300–1200 mg/day, with clinical studies in PCOS using 600 mg/day as a common benchmark. DCI contains no protein, fat, or dietary fiber, and contributes negligible caloric value (~0 kcal per functional dose). It is devoid of vitamins and minerals intrinsically. As a bioactive, its primary activity lies in its role as a precursor to DCI-inositolphosphoglycan (DCI-IPG), a putative insulin second messenger that activates pyruvate dehydrogenase phosphatase, facilitating glucose oxidation. In human tissues, DCI is derived endogenously via epimerase-mediated conversion from myo-inositol (MI) at tissue-specific rates; the kidney exhibits the highest conversion activity. Plasma DCI concentrations in healthy individuals are approximately 4–10 µmol/L, substantially lower than myo-inositol (~100–150 µmol/L), reflecting an MI:DCI physiological ratio of approximately 40:1 in plasma and 100:1 in follicular fluid. Bioavailability of supplemental DCI is reported as high (~70–85%) with rapid intestinal absorption via sodium-dependent and facilitated transport mechanisms, reaching peak plasma levels within 2–3 hours post-ingestion. Foods naturally containing DCI include buckwheat (approximately 0.2–1.7 mg/g dry weight), carob, and certain legumes, though dietary intake is generally insufficient to achieve therapeutic plasma concentrations without supplementation. ## Dosage & Preparation No clinically studied dosage ranges, forms, or standardization details are available in the research results. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions D-chiro-inositol appears generally well-tolerated based on limited available data, though comprehensive safety studies are lacking. Potential gastrointestinal effects including nausea or stomach upset may occur, similar to other inositol forms. No significant drug interactions have been reported, but individuals taking diabetes medications should monitor blood glucose levels due to potential effects on [insulin sensitivity](/ingredients/condition/weight-management). Safety during pregnancy and lactation has not been established through clinical studies. ## Scientific Research The research dossier provides no information on human clinical trials, RCTs, or meta-analyses for D-Chiro-Inositol. No PubMed PMIDs, study designs, sample sizes, or clinical outcomes are available in the provided search results. ## Historical & Cultural Context No historical context, traditional medicine systems, or duration of use is documented in the available research results. ## Synergistic Combinations Myo-inositol, Chromium picolinate, Alpha-lipoic acid, Magnesium, Vitamin D ## Frequently Asked Questions ### What is the difference between D-chiro-inositol and myo-inositol? D-chiro-inositol and myo-inositol are different stereoisomers with distinct biological functions. Myo-inositol can be converted to D-chiro-inositol by the enzyme epimerase, and they have different tissue distributions and roles in insulin signaling pathways. ### How much D-chiro-inositol should I take daily? There is no established recommended daily dosage for D-chiro-inositol due to limited clinical research. Studies have used varying amounts, but optimal dosing has not been determined through rigorous clinical trials. ### Can D-chiro-inositol help with PCOS symptoms? While D-chiro-inositol is involved in ovarian function regulation through cell signaling pathways, there is insufficient clinical evidence to support its use for PCOS. More human studies are needed to establish efficacy for this condition. ### Is D-chiro-inositol safe to take with diabetes medication? No significant interactions have been reported, but individuals should consult healthcare providers before combining D-chiro-inositol with diabetes medications. Blood glucose monitoring may be advisable due to potential effects on insulin sensitivity pathways. ### How long does it take for D-chiro-inositol to work? The timeframe for D-chiro-inositol effects is unknown due to limited clinical data. Since it works through cellular signaling pathways and metabolic processes, any potential benefits would likely require consistent supplementation over weeks to months. ### What does clinical research show about D-chiro-inositol's effectiveness? Current evidence for D-chiro-inositol is limited, with most data coming from biochemical and mechanistic studies rather than large-scale human trials. While research demonstrates its role in insulin signaling and ovarian cell function, the clinical significance of these pathways for symptom improvement requires more rigorous human studies. Existing research suggests potential benefits for metabolic and reproductive health, but definitive efficacy claims await additional clinical evidence. ### Who is most likely to benefit from D-chiro-inositol supplementation? D-chiro-inositol may be most beneficial for individuals with insulin resistance, PCOS, or metabolic concerns, since it plays a direct role in insulin signaling pathways. Women with ovulatory dysfunction or fertility concerns may also benefit due to its involvement in ovarian cell regulation. However, personalized assessment by a healthcare provider is recommended, as individual conversion rates and tissue-specific responses vary significantly. ### How does D-chiro-inositol absorption and effectiveness vary between individuals? D-chiro-inositol's effectiveness depends on tissue-specific conversion rates from myo-inositol and individual metabolic capacity, meaning absorption and action can vary significantly between people. Factors such as insulin sensitivity, hormonal status, and baseline inositol metabolism influence how efficiently the body utilizes supplemental D-chiro-inositol. This individual variability underscores why response times and dosage effectiveness differ across users, even at the same supplementation levels. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*